Main investigators
The research team constitutes a carefully selected group of experienced and young PIs with complementary competence needed to solve the objectives of the centre
Main content
The center director Eystein Husebye is former and current coordinator of FP7 and Horizon 2020 projects and an expert in the field of rare autoimmune diseases. The center will build on his team of young PIs and close collaborators and the infrastructure and technology built up at the Department of Clinical Science UiB, the corresponding clinical departments at Haukeland University Hospital (HUS), and the long-term close collaboration with Professor Olle Kämpe at Karolinska Institute (KI). The main PIs are:
Professor Eystein Husebye (director) - UiB/HUS: Expert in clinical and experimental endocrinology and autoimmunity, with a track record in identification of genetic variants and autoantigens as well as clinical and registry studies.
Anette Bøe Wolff (PI, deputy director) - UiB, an expert in molecular biology and functional studies of genetic disorders in autoimmunity.
Professor Kristian Løvås (PI, deputy director) - HUS, a clinical endocrinologist with vast experience in epidemiology, clinical trials, and patient registries.
Professor Olle Kämpe (PI) - KI, a world-leading expert in molecular medicine within the field of endocrinology and immunology; member of The Royal Swedish Academy of Science and The Nobel Prize Committee. Excellent track record in identification of novel autoantigens, clinical and registry studies as well as comparative genetics (dogs, chickens).
Professor Per Knappskog (PI), a world-leading expert in genomics and bioinformatics with an excellent track record in identifying novel monogenic diseases.
Professor Emmet McCormack (PI) - UiB, an expert in developing new immunomodulatorytherapies in leukemia; he will play a key role in designing new immune therapies.
Researcher Eirik Bratland (PI) - UiB, an expert in experimental autoimmunity using in vitro cell systems and animal models for the study of pathogenesis.
Postdoc Bergithe Oftedal (PI) - UiB, an expert in molecular biology and functional studies of genetic disorders in autoimmunity, recently characterized a new form of APS.
Ass. professor Jakub Abramson (collaborator) - The Weizmann Institute of Science, a leading expert in autoimmune animal models related to immunological tolerance, especially in mouse models. User of CRISPR/Cas9 technology to generate mouse models.
